Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated at StockNews.com
Analysts at StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a research report issued on Wednesday. The firm set a “sell” rating on the stock. Separately, LADENBURG THALM/SH SH raised shares of Ayala Pharmaceuticals from a “neutral” rating to a “buy” rating in a report on Tuesday, May 30th. […]